1. Home
  2. ICHR vs AUPH Comparison

ICHR vs AUPH Comparison

Compare ICHR & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICHR
  • AUPH
  • Stock Information
  • Founded
  • ICHR 1999
  • AUPH 1993
  • Country
  • ICHR United States
  • AUPH Canada
  • Employees
  • ICHR N/A
  • AUPH N/A
  • Industry
  • ICHR Semiconductors
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICHR Technology
  • AUPH Health Care
  • Exchange
  • ICHR Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • ICHR 999.2M
  • AUPH 1.0B
  • IPO Year
  • ICHR 2016
  • AUPH 1999
  • Fundamental
  • Price
  • ICHR $32.52
  • AUPH $7.52
  • Analyst Decision
  • ICHR Strong Buy
  • AUPH Strong Buy
  • Analyst Count
  • ICHR 8
  • AUPH 3
  • Target Price
  • ICHR $42.50
  • AUPH $10.33
  • AVG Volume (30 Days)
  • ICHR 241.6K
  • AUPH 850.1K
  • Earning Date
  • ICHR 11-04-2024
  • AUPH 11-07-2024
  • Dividend Yield
  • ICHR N/A
  • AUPH N/A
  • EPS Growth
  • ICHR N/A
  • AUPH N/A
  • EPS
  • ICHR N/A
  • AUPH N/A
  • Revenue
  • ICHR $819,230,000.00
  • AUPH $207,105,000.00
  • Revenue This Year
  • ICHR $3.64
  • AUPH $36.08
  • Revenue Next Year
  • ICHR $17.73
  • AUPH $19.41
  • P/E Ratio
  • ICHR N/A
  • AUPH N/A
  • Revenue Growth
  • ICHR N/A
  • AUPH 29.35
  • 52 Week Low
  • ICHR $22.26
  • AUPH $4.71
  • 52 Week High
  • ICHR $46.43
  • AUPH $10.05
  • Technical
  • Relative Strength Index (RSI)
  • ICHR 66.44
  • AUPH 61.49
  • Support Level
  • ICHR $26.82
  • AUPH $7.03
  • Resistance Level
  • ICHR $28.62
  • AUPH $7.50
  • Average True Range (ATR)
  • ICHR 0.92
  • AUPH 0.22
  • MACD
  • ICHR 0.47
  • AUPH 0.02
  • Stochastic Oscillator
  • ICHR 89.21
  • AUPH 94.37

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, the United Kingdom, Singapore, Malaysia, Korea, and Mexico, of which a majority of the revenue is generated from Singapore.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: